Disc Medicine, Inc. (IRON)
USD 41.34
(-9.68%)
USD 41.34
(-9.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -358.28 Million USD | -85.37% |
| 2022 | -193.27 Million USD | -123.74% |
| 2021 | -86.38 Million USD | -522.87% |
| 2020 | 20.42 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -499.1 Million USD | 18.13% |
| 2024 Q1 | -340.58 Million USD | 4.94% |
| 2023 Q2 | -375.5 Million USD | -59.68% |
| 2023 Q4 | -358.28 Million USD | 2.79% |
| 2023 FY | -358.28 Million USD | -85.37% |
| 2023 Q1 | -235.16 Million USD | -21.67% |
| 2023 Q3 | -368.58 Million USD | 1.84% |
| 2022 Q4 | -193.27 Million USD | -89.98% |
| 2022 FY | -193.27 Million USD | -123.74% |
| 2022 Q2 | -105.74 Million USD | 7.97% |
| 2022 Q1 | -114.9 Million USD | 12.44% |
| 2022 Q3 | -101.73 Million USD | 3.79% |
| 2021 Q1 | -175.85 Million USD | -14408.65% |
| 2021 FY | -86.38 Million USD | -522.87% |
| 2021 Q4 | -131.22 Million USD | 8.51% |
| 2021 Q3 | -143.42 Million USD | 10.13% |
| 2021 Q2 | -159.58 Million USD | 9.25% |
| 2020 Q4 | -1.21 Million USD | 0.0% |
| 2020 FY | 20.42 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -540.474% |
| Alkermes plc | -166.73 Million USD | -114.875% |
| Agenus Inc. | 274.13 Million USD | 230.695% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 119.16% |
| Aptorum Group Limited | 1.35 Million USD | 26501.537% |
| Ardelyx, Inc. | 34.51 Million USD | 1138.135% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 8471.051% |
| Bicycle Therapeutics plc | -481.46 Million USD | 25.586% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1090.739% |
| ChromaDex Corporation | -24.04 Million USD | -1389.858% |
| Chimerix, Inc. | -25.51 Million USD | -1304.087% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 5241.749% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1413.203% |
| CRISPR Therapeutics AG | -150.84 Million USD | -137.516% |
| Precision BioSciences, Inc. | -85.41 Million USD | -319.484% |
| Dyadic International, Inc. | -6.37 Million USD | -5517.363% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2148.673% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4774.247% |
| Lantern Pharma Inc. | -21.7 Million USD | -1550.815% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -224.128% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -4093.768% |
| Incyte Corporation | -3.17 Billion USD | 88.716% |
| IO Biotech, Inc. | -140.69 Million USD | -154.644% |
| Jaguar Health, Inc. | 29.39 Million USD | 1319.016% |
| Novavax, Inc. | -298.29 Million USD | -20.11% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 6813.153% |
| Opthea Limited | 28.15 Million USD | 1372.42% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -2034.022% |
| ContextLogic Inc. | -232 Million USD | -54.431% |
| MiMedx Group, Inc. | -33.9 Million USD | -956.845% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3614.282% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -15362.962% |
| NextCure, Inc. | -6.47 Million USD | -5431.589% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -609.453% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -5516.57% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 3045.598% |
| Vaxcyte, Inc. | -368.22 Million USD | 2.701% |
| PDS Biotechnology Corporation | -32.7 Million USD | -995.362% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2173.625% |
| Pharming Group N.V. | 109.8 Million USD | 426.291% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1959.56% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -104.463% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1834.578% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1834.578% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4946.211% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -6014.01% |
| Acelyrin, Inc. | -216.9 Million USD | -65.18% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -6286.167% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -20681.961% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1133.284% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -5166.515% |
| Senti Biosciences, Inc. | 1.74 Million USD | 20690.862% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -94.078% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -362.591% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5810.277% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 359210.545% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 57151.115% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -206.103% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -112.967% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 423.154% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4616.706% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -177.492% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 5296.547% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -47.828% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1946.175% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -13.128% |
| MEI Pharma, Inc. | -3.7 Million USD | -9570.202% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2963.728% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 321.514% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1389.105% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4774.247% |
| Precigen, Inc. | -481 Thousand USD | -74386.694% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2644.429% |
| AlloVir, Inc. | -62.69 Million USD | -471.494% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -544.228% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 681.002% |
| ImmuCell Corporation | 10.99 Million USD | 3359.897% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -132.43% |
| Onconetix, Inc. | 5.33 Million USD | 6820.158% |
| PureTech Health plc | -167.19 Million USD | -114.287% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1076.234% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1774.051% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -7198.452% |
| Seer, Inc. | -4.24 Million USD | -8350.024% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1390.54% |
| Innoviva, Inc. | 255.56 Million USD | 240.193% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -541.345% |
| ESSA Pharma Inc. | -33.62 Million USD | -965.628% |
| GlycoMimetics, Inc. | -40.98 Million USD | -774.188% |
| GT Biopharma, Inc. | -1.02 Million USD | -34991.185% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -428.571% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 684.882% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -167.216% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2485.746% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1140.929% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -475490.039% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1060.913% |
| Aptose Biosciences Inc. | -8.19 Million USD | -4272.023% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -11350.27% |
| Soligenix, Inc. | -4.95 Million USD | -7135.666% |
| Century Therapeutics, Inc. | 847 Thousand USD | 42400.0% |
| Kura Oncology, Inc. | -20.11 Million USD | -1680.898% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -775.436% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -4166.266% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 19767.453% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -11106.788% |
| Autolus Therapeutics plc | -186.59 Million USD | -92.006% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -626.677% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -29.909% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1145.526% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 317.975% |
| GRI Bio, Inc. | -1.79 Million USD | -19871.07% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3888.413% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -977.31% |
| IGM Biosciences, Inc. | -72.6 Million USD | -393.459% |
| INmune Bio, Inc. | -25.41 Million USD | -1309.945% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 337.349% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -607.24% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2104.891% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -12319.071% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1042.473% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -769.931% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1223.666% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 194.796% |
| Verastem, Inc. | -37.27 Million USD | -861.106% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3848.87% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -590.835% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -2267.235% |
| Histogen Inc. | -7.48 Million USD | -4685.375% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1558.185% |
| Surrozen, Inc. | -32.66 Million USD | -996.868% |
| Organovo Holdings, Inc. | -1.5 Million USD | -23674.453% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8423.422% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1989.647% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 13795.757% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 8720.813% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -4174.843% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -724.734% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2357.875% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -13.098% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -49519.284% |
| Apollomics, Inc. | -27.39 Million USD | -1207.834% |
| Amarin Corporation plc | -191.04 Million USD | -87.542% |
| Mesoblast Limited | 55.96 Million USD | 740.21% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2356.672% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1316.578% |
| Synaptogenix, Inc. | -28.66 Million USD | -1150.043% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -38177.885% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 835.207% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -41459.63% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4830.871% |
| Exelixis, Inc. | -73.05 Million USD | -390.46% |
| Better Therapeutics, Inc. | -860 Thousand USD | -41560.581% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1392.029% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -48.436% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 48775.119% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4716.812% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 28671.053% |
| Gritstone bio, Inc. | 39.49 Million USD | 1007.27% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -326.013% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -13511.776% |
| Avid Bioservices, Inc. | 169.72 Million USD | 311.091% |
| Insmed Incorporated | 721.62 Million USD | 149.65% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3819.275% |
| MediWound Ltd. | -5.32 Million USD | -6632.074% |
| OmniAb, Inc. | 9.2 Million USD | 3993.089% |
| Alector, Inc. | -35.63 Million USD | -905.362% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 516.746% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -7170.313% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2806.254% |
| Zai Lab Limited | -775 Million USD | 53.77% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 205.205% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1564.488% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -334.385% |
| Immunic, Inc. | -45.34 Million USD | -690.21% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -85.431% |
| Veracyte, Inc. | -203.82 Million USD | -75.78% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 156.131% |
| FibroGen, Inc. | 56.76 Million USD | 731.143% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4123.369% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -12573.173% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -17205.352% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 107.805% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -10623.765% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -115.879% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2105.828% |
| Galecto, Inc. | -21.21 Million USD | -1588.73% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1406.332% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 122.829% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1364.045% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -3013.592% |
| XBiotech Inc. | -200.02 Million USD | -79.12% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -326.013% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 8012.566% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -916.025% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -363.986% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 6395.572% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -110.24% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -287.859% |
| Vaxxinity, Inc. | 10.13 Million USD | 3636.133% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 148.662% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -3227.414% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -443.212% |
| NexImmune, Inc. | -3.13 Million USD | -11333.37% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -10276.917% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -2270.924% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1222.07% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3891.521% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -287502.649% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -783.075% |
| Ainos, Inc. | 4.07 Million USD | 8885.859% |
| Pluri Inc. | 22.82 Million USD | 1669.412% |
| Prothena Corporation plc | -608.34 Million USD | 41.106% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -201.695% |
| Celularity Inc. | 65.19 Million USD | 649.595% |
| Rallybio Corporation | -24.1 Million USD | -1386.52% |
| Cue Biopharma, Inc. | -33.81 Million USD | -959.407% |
| MeiraGTx Holdings plc | -40.3 Million USD | -788.991% |
| Omeros Corporation | 331.17 Million USD | 208.184% |
| Humacyte, Inc. | -22.48 Million USD | -1493.351% |
| Immunocore Holdings plc | -358.59 Million USD | 0.087% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1357.908% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1059.448% |
| Blueprint Medicines Corporation | 702.83 Million USD | 150.976% |
| CalciMedica, Inc. | -5.53 Million USD | -6378.861% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -90.352% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3407.744% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -794.875% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -977.44% |
| Pulmatrix, Inc. | -10.41 Million USD | -3339.388% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -5894.328% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -839.335% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -221.611% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -497.693% |
| Cytokinetics, Incorporated | 642.37 Million USD | 155.775% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -6052.859% |
| Nutriband Inc. | -251.65 Thousand USD | -142268.78% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -950.092% |
| Vor Biopharma Inc. | 4.3 Million USD | 8432.116% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 94.064% |
| Evogene Ltd. | -19.63 Million USD | -1724.799% |
| ProKidney Corp. | -56.23 Million USD | -537.103% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -636.113% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3778.681% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 126.269% |
| CorMedix Inc. | -43.05 Million USD | -732.195% |
| BioLineRx Ltd. | 7.33 Million USD | 4983.874% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1204.5% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 876.391% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1154.573% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 16162.602% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1470.306% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2120.192% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -377.237% |
| MediciNova, Inc. | -50.78 Million USD | -605.506% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -354.642% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1592613.936% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5452.515% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -79.301% |
| Biomea Fusion, Inc. | -166.57 Million USD | -115.093% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -100.185% |
| Mereo BioPharma Group plc | -51.46 Million USD | -596.11% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -277.758% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -21.964% |
| Absci Corporation | -72.59 Million USD | -393.514% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7946.715% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -52.826% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -280.296% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -274.395% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -816.953% |
| Allakos Inc. | -24.97 Million USD | -1334.559% |
| Imunon, Inc. | -4.21 Million USD | -8402.458% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2330.342% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -164.609% |
| BioAtla, Inc. | -109.01 Million USD | -228.665% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 48775.119% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -38055.591% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 3094.158% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1589.766% |
| XOMA Corporation | -29 Million USD | -1135.452% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2063.533% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3873.835% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4709.787% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -187.462% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -72.115% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -338.109% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -286.233% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -41600.148% |
| Akari Therapeutics, Plc | -3.84 Million USD | -9218.101% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22176.727% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 125.946% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30054.907% |
| UroGen Pharma Ltd. | 4.39 Million USD | 8259.44% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 415.719% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 497975.268% |
| Orgenesis Inc. | 21.78 Million USD | 1744.698% |
| Entera Bio Ltd. | -10.62 Million USD | -3270.787% |
| GH Research PLC | -78.07 Million USD | -358.882% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1507.506% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1243.94% |
| Xencor, Inc. | 29.64 Million USD | 1308.612% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -18088.589% |
| Replimune Group, Inc. | 1.41 Million USD | 25474.008% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -146192.077% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -183.412% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30054.907% |
| Portage Biotech Inc. | -4.98 Million USD | -7092.953% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1592613.936% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -441.848% |
| OncoCyte Corporation | -6.56 Million USD | -5359.104% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 40023.759% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -7764.554% |
| Purple Biotech Ltd. | -14.13 Million USD | -2434.17% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1408.171% |
| scPharmaceuticals Inc. | -6.54 Million USD | -5374.118% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -2046.402% |
| HilleVax, Inc. | -165.48 Million USD | -116.504% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -14016.667% |
| Tharimmune, Inc. | -10.93 Million USD | -3176.355% |
| Genprex, Inc. | -6.73 Million USD | -5217.612% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 2.854% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -305.02% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -25473.233% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -10701.532% |
| OKYO Pharma Limited | -826.84 Thousand USD | -43230.939% |
| Savara Inc. | 153 Thousand USD | 234270.588% |
| Curis, Inc. | -23.88 Million USD | -1399.9% |
| Daré Bioscience, Inc. | -5.15 Million USD | -6846.242% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -46069.518% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5671.279% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 30334.684% |
| BeiGene, Ltd. | -2.25 Billion USD | 84.098% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 3003.765% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 41.092% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -93.054% |
| Erasca, Inc. | -37.21 Million USD | -862.707% |
| bluebird bio, Inc. | 108.57 Million USD | 429.997% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -27719.159% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 194.596% |
| DBV Technologies S.A. | -126.98 Million USD | -182.142% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -27719.159% |
| Moderna, Inc. | -2.9 Billion USD | 87.675% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -3360.983% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -3196.66% |
| Molecular Templates, Inc. | 707 Thousand USD | 50776.238% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1042.077% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 203.368% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -336.598% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -290.582% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1010.191% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -942.242% |
| MacroGenics, Inc. | -66.98 Million USD | -434.868% |
| RenovoRx, Inc. | -1.17 Million USD | -30443.99% |
| Adicet Bio, Inc. | -138.78 Million USD | -158.152% |
| Prime Medicine, Inc. | -27.94 Million USD | -1182.277% |
| Aditxt, Inc. | 18.12 Million USD | 2077.172% |
| Adagene Inc. | -87.62 Million USD | -308.869% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8501.301% |
| Quantum-Si incorporated | -118.55 Million USD | -202.201% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1095.087% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4693.578% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -638.587% |
| SciSparc Ltd. | -2.06 Million USD | -17250.169% |
| Vericel Corporation | 1.27 Million USD | 28156.46% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2887.741% |
| Minerva Neurosciences, Inc. | 41 Million USD | 973.766% |
| Generation Bio Co. | 31.44 Million USD | 1239.281% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -104.307% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1058.623% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 407.292% |
| Invivyd, Inc. | -198.47 Million USD | -80.516% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -296.899% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -14842.768% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -406.118% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -5149.538% |
| 2seventy bio, Inc. | 181.71 Million USD | 297.166% |
| ADMA Biologics, Inc. | 90.06 Million USD | 497.798% |
| Clene Inc. | 3.34 Million USD | 10826.976% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3844.652% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1565.571% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5452.515% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -4.114% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1278.021% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 301.66% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -8656.572% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 7262.755% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -6778.115% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -174.958% |
| Evaxion Biotech A/S | 5.28 Million USD | 6876.841% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -218.28% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -172.928% |
| Trevena, Inc. | 2.25 Million USD | 15967.183% |
| Surrozen, Inc. | -32.66 Million USD | -996.868% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -595.556% |
| Cingulate Inc. | 3.08 Million USD | 11722.376% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -12098.876% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 5085.126% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3756.121% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -351.674% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -172.557% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -239.468% |
| Clearmind Medicine Inc. | -3.94 Million USD | -8987.344% |
| Kronos Bio, Inc. | -36.05 Million USD | -893.734% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3907.854% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 24671.316% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -560.353% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2585.231% |
| ImmunityBio, Inc. | 618.22 Million USD | 157.953% |
| Korro Bio, Inc. | -132.94 Million USD | -169.5% |
| Kineta, Inc. | -4.54 Million USD | -7789.914% |
| BioVie Inc. | -17.73 Million USD | -1920.494% |
| Codexis, Inc. | -43.27 Million USD | -727.993% |
| Celularity Inc. | 65.19 Million USD | 649.595% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -11205.806% |
| Celcuity Inc. | 6.78 Million USD | 5381.647% |
| Virax Biolabs Group Limited | -3.36 Million USD | -10547.458% |
| Cibus, Inc. | -8.07 Million USD | -4335.269% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -8372.003% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 7939.847% |
| IN8bio, Inc. | -16.38 Million USD | -2086.107% |
| Kodiak Sciences Inc. | -103.87 Million USD | -244.916% |
| Annexon, Inc. | -193.75 Million USD | -84.914% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 995325.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1947.437% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -10098.719% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 133.984% |
| Eyenovia, Inc. | 1.25 Million USD | 28564.323% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1431.652% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -10947.826% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -977.634% |
| Arcellx, Inc. | -296.95 Million USD | -20.65% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1736.773% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -508.545% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1628.571% |
| Moolec Science SA | 117.61 Thousand USD | 304719.269% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -833.048% |
| Geron Corporation | 14.76 Million USD | 2527.214% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -844.884% |
| Royalty Pharma plc | 5.65 Billion USD | 106.332% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -153.344% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -5026.045% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -6580.784% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -154.586% |
| Humacyte, Inc. | -22.48 Million USD | -1493.351% |
| Structure Therapeutics Inc. | -124.33 Million USD | -188.148% |
| 89bio, Inc. | -289.05 Million USD | -23.95% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1319.384% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -19994.279% |
| Genelux Corporation | -6.89 Million USD | -5093.231% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1053.55% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 528.571% |
| Notable Labs, Ltd. | -9.77 Million USD | -3564.904% |
| Liquidia Corporation | -80.17 Million USD | -346.868% |
| Mustang Bio, Inc. | -3.73 Million USD | -9489.963% |
| Immunovant, Inc. | -635.22 Million USD | 43.598% |
| Quantum-Si incorporated | -118.55 Million USD | -202.201% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1939.86% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -8547.864% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4563.448% |
| Acasti Pharma Inc. | -23 Million USD | -1457.405% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -10540.233% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2104.891% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -160.114% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -11396.771% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1511.555% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1829.458% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -111.652% |
| PepGen Inc. | -60.67 Million USD | -490.541% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1459.371% |
| United Therapeutics Corporation | -507.7 Million USD | 29.431% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1773.267% |
| Solid Biosciences Inc. | -47.75 Million USD | -650.327% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -41459.63% |
| Immuneering Corporation | -54.94 Million USD | -552.097% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8423.422% |
| Silo Pharma, Inc. | -3.52 Million USD | -10065.996% |
| Belite Bio, Inc | -87.27 Million USD | -310.538% |
| XOMA Corporation | -29 Million USD | -1135.452% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -406.784% |
| Bionomics Limited | 227 Million USD | 257.826% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -208.114% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14044.532% |
| uniQure N.V. | -102.95 Million USD | -248.011% |
| Cassava Sciences, Inc. | -121.13 Million USD | -195.768% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8501.301% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 974.902% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2895.41% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -11479.116% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 338100.943% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -10947.826% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4123.369% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4731.189% |
| Altimmune, Inc. | -134.48 Million USD | -166.406% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 280.891% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14044.532% |
| Compugen Ltd. | -12.9 Million USD | -2676.511% |
| Peak Bio, Inc. | 10.34 Million USD | 3564.947% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -126501.06% |
| Benitec Biopharma Inc. | -50.58 Million USD | -608.317% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -243.385% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1923.777% |
| Zura Bio Limited | -99.8 Million USD | -258.977% |
| PolyPid Ltd. | 6.17 Million USD | 5906.823% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 583.38% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1923.777% |
| Instil Bio, Inc. | 75.35 Million USD | 575.439% |
| argenx SE | -2.02 Billion USD | 82.341% |
| Immunome, Inc. | -97.02 Million USD | -269.251% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1492.714% |
| Verona Pharma plc | -220.44 Million USD | -62.528% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -399.395% |
| Shattuck Labs, Inc. | -121.42 Million USD | -195.066% |
| CervoMed Inc. | -7.79 Million USD | -4497.563% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -93.144% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -8093.025% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -171.961% |
| Moolec Science SA | 117.61 Thousand USD | 304719.269% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -15559.292% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2353.569% |
| AnaptysBio, Inc. | -18.15 Million USD | -1873.891% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1874.0% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -409.059% |
| NeurAxis, Inc. | 145.7 Thousand USD | 246003.226% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 3289.824% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1157.435% |
| Achilles Therapeutics plc | -126.92 Million USD | -182.28% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -399.395% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -54538.495% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1624.675% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 24671.316% |
| Nutriband Inc. | -251.65 Thousand USD | -142268.78% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2620.226% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4715.605% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 205.316% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1609.505% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 19.932% |
| Palisade Bio, Inc. | -12.06 Million USD | -2870.082% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -155.348% |
| Beam Therapeutics Inc. | -262.72 Million USD | -36.373% |
| Neurogene Inc. | -131.95 Million USD | -171.518% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1742.285% |
| AEON Biopharma, Inc. | -4.88 Million USD | -7241.824% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 5.013% |
| Sesen Bio, Inc. | -112.55 Million USD | -218.322% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -258.783% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -15160.332% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -818.057% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -330.202% |
| Athira Pharma, Inc. | -88.99 Million USD | -302.567% |
| Vaccinex, Inc. | -1.28 Million USD | -27716.848% |
| HCW Biologics Inc. | 2.85 Million USD | 12641.884% |
| XOMA Corporation | -29 Million USD | -1135.452% |
| Nektar Therapeutics | 210.24 Million USD | 270.415% |
| Arvinas, Inc. | -313.8 Million USD | -14.175% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22176.727% |
| Merus N.V. | -192.88 Million USD | -85.749% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 697.284% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -5064.039% |
| Rezolute, Inc. | -68.16 Million USD | -425.585% |
| Clene Inc. | 3.34 Million USD | 10826.976% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2616.926% |
| BeyondSpring Inc. | -13.75 Million USD | -2504.733% |
| Synlogic, Inc. | -6.68 Million USD | -5259.476% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 31694.444% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -4137.504% |
| Peak Bio, Inc. | 10.34 Million USD | 3564.947% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -334.702% |
| Krystal Biotech, Inc. | -350.23 Million USD | -2.298% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 388.645% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -112.006% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -11248.263% |
| MannKind Corporation | 143.89 Million USD | 348.981% |
| Ikena Oncology, Inc. | -109.15 Million USD | -228.228% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4632.281% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -982.42% |
| Gossamer Bio, Inc. | 180.35 Million USD | 298.653% |
| CohBar, Inc. | -5.93 Million USD | -5941.093% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1104.387% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7946.715% |
| Legend Biotech Corporation | -949.39 Million USD | 62.262% |
| Mural Oncology plc | -255.84 Million USD | -40.039% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1212.156% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -7505.779% |
| Champions Oncology, Inc. | 4.81 Million USD | 7545.574% |
| REGENXBIO Inc. | 54.76 Million USD | 754.179% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -133136.026% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -137.234% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3875.597% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -344.06% |
| Vaxart, Inc. | -8.24 Million USD | -4247.543% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -613.992% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -181.744% |
| Cellectis S.A. | -43.85 Million USD | -716.967% |
| Longeveron Inc. | -2.9 Million USD | -12220.53% |
| Repare Therapeutics Inc. | -107.85 Million USD | -232.178% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 136.998% |
| Inozyme Pharma, Inc. | 12 Million USD | 3084.68% |
| Revolution Medicines, Inc. | -608.2 Million USD | 41.092% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -29028.537% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -35.141% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -138.739% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2189.774% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -48316.351% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.254% |
| Denali Therapeutics Inc. | -74.86 Million USD | -378.569% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2887.741% |
| Veru Inc. | 4.77 Million USD | 7595.467% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -3085.853% |
| Cingulate Inc. | 3.08 Million USD | 11722.376% |
| Passage Bio, Inc. | 4.58 Million USD | 7914.198% |
| Context Therapeutics Inc. | -14.44 Million USD | -2379.483% |
| Exicure, Inc. | 5.84 Million USD | 6225.509% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -55.52% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -805.436% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2383.354% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -509.104% |
| Nuvalent, Inc. | -335.38 Million USD | -6.826% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 20758.048% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -381.03% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3930.157% |
| OmniAb, Inc. | 9.2 Million USD | 3993.089% |
| Anew Medical, Inc. | 1.43 Million USD | 25111.501% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2287.073% |
| Lipocine Inc. | -4.75 Million USD | -7435.473% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -226.22% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2452.314% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -607.24% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1539.342% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -5230.769% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -444.277% |
| Ocugen, Inc. | -32.52 Million USD | -1001.691% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -318.675% |
| Q32 Bio Inc. | -37.94 Million USD | -844.137% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -56951.115% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2548.245% |
| Equillium, Inc. | -22.39 Million USD | -1500.04% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1301.287% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -998.12% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -144417.677% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 367.29% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 11303.283% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 109185.346% |
| Dominari Holdings Inc. | 195 Thousand USD | 183833.846% |
| Edesa Biotech, Inc. | -5.26 Million USD | -6702.49% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3917.954% |
| Bio-Techne Corporation | 267.74 Million USD | 233.813% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2110.383% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -203.386% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -4163.727% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2732.037% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -46.166% |
| Nkarta, Inc. | 57.29 Million USD | 725.283% |
| BioCardia, Inc. | 212 Thousand USD | 169100.472% |
| Iterum Therapeutics plc | 13.43 Million USD | 2766.178% |